Healthcare entity

BIO International Convention 2026

event

Every one of those 1 sits in a single category, market-trends. BIO International Convention 2026 is most often covered alongside Dong‑Hoon Lee, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention BIO International Convention 2026, all published on June 23, 2026.

Last mentioned: Jun 23, 2026

Entity pulse

Recent coverage · BIO International Convention 2026

1 story
8 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about BIO International Convention 2026

Every one of those 1 sits in a single category, market-trends. BIO International Convention 2026 is most often covered alongside Dong‑Hoon Lee, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention BIO International Convention 2026, all published on June 23, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering BIO International Convention 2026. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning BIO International Convention 2026 1

Market Trends Strongly positive

AI‑Powered CNS Drug Discovery Deal Hits $2.5B for Neuroimmune Disorders

A breakthrough $2.5B collaboration between AI drug discoverer Insilico Medicine and CNS specialist SK Biopharmaceuticals aims to tackle devastating neuroimmune disorders that have long defied conventional drug development. By combining generative AI with established clinical expertise, the partnership could dramatically shorten timelines and deliver first‑in‑class therapies to patients with conditions like Alzheimer's, multiple sclerosis, and rare neuroinflammatory diseases.

2 sources

BIO International Convention 2026 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.